Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cohn

Showing results (611-620 of 730) with videos related to

Pageof 73
Sort By:
Oncogene|June 14, 2016
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic targetUksha Saini, Shan Naidu, Adam C ElNaggar, et al.
American Journal of Obstetrics and Gynecology|September 20, 2016
Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative womenLisa B Haddad, Kristin M Wall, C Christina Mehta, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2015
Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic ChemotherapyCaroline C Billingsley, Samuel N Jacobson, Sarah M Crafton, et al.
Gynecologic Oncology|March 15, 2013
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trialLouise A Brinton, Ashley S Felix, D Scott McMeekin, et al.
Journal of Neurology|August 11, 2014
Mutation frequency of PRKAR1B and the major familial dementia genes in a Dutch early onset dementia cohortP E Cohn-Hokke, T H Wong, P Rizzu, et al.
Gynecologic Oncology|October 12, 2016
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary studyArlene E Garcia-Soto, James J Java, Wilberto Nieves Neira, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2014
Pregnancy intentions among women living with HIV in the United StatesLisa Rahangdale, Amanda Stewart, Robert D Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2014
Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group studyPaul A DiSilvestro, Shamshad Ali, Peter S Craighead, et al.
Gynecologic Oncology Reports|February 23, 2024
Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State UniversityMonica D Levine, Vincent M Wagner, Courtney J Riedinger, et al.
Oncogene|April 10, 2025
Circulating extracellular vesicles protein expression for early prediction of platinum-resistance in high-grade serous ovarian cancerVincent Wagner, Molly Morton, Kalpana Deepa Priya Dorayappan, et al.
Pageof 73

Showing results (611-620 of 730) with videos related to

Sort By:
Pageof 73
Oncogene|June 14, 2016
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic targetUksha Saini, Shan Naidu, Adam C ElNaggar, et al.
American Journal of Obstetrics and Gynecology|September 20, 2016
Trends of and factors associated with live-birth and abortion rates among HIV-positive and HIV-negative womenLisa B Haddad, Kristin M Wall, C Christina Mehta, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2015
Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic ChemotherapyCaroline C Billingsley, Samuel N Jacobson, Sarah M Crafton, et al.
Gynecologic Oncology|March 15, 2013
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trialLouise A Brinton, Ashley S Felix, D Scott McMeekin, et al.
Journal of Neurology|August 11, 2014
Mutation frequency of PRKAR1B and the major familial dementia genes in a Dutch early onset dementia cohortP E Cohn-Hokke, T H Wong, P Rizzu, et al.
Gynecologic Oncology|October 12, 2016
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary studyArlene E Garcia-Soto, James J Java, Wilberto Nieves Neira, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 15, 2014
Pregnancy intentions among women living with HIV in the United StatesLisa Rahangdale, Amanda Stewart, Robert D Stewart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2014
Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group studyPaul A DiSilvestro, Shamshad Ali, Peter S Craighead, et al.
Gynecologic Oncology Reports|February 23, 2024
Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State UniversityMonica D Levine, Vincent M Wagner, Courtney J Riedinger, et al.
Oncogene|April 10, 2025
Circulating extracellular vesicles protein expression for early prediction of platinum-resistance in high-grade serous ovarian cancerVincent Wagner, Molly Morton, Kalpana Deepa Priya Dorayappan, et al.
Pageof 73